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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S237the nine SNPs. Luciferase reporter assays were used to assess if the
presence of any of the alleles inﬂuenced the enhancer activity of the
constructs in the U2OS osteosarcoma cell line, which expresses both
genes.
Results: There was a signiﬁcant increase in PTHLH expression in OA
females relative to NOF females (p ¼ 0.02), however there was no evi-
dence for any signiﬁcant correlation between PTHLH expression and
rs10492367 genotype in OA cartilage. Similarly, there was no correla-
tion between KLHDC5 expression and rs10492367 genotype. In addi-
tion, although allelic imbalance was observed, it did not correlate with
the OA association SNP genotype. In the U2OS cell line luciferase assays,
the OA associated alleles of the intergenic SNPs rs11049206 and
rs58649696 resulted in signiﬁcantly reduced enhancer activities rela-
tive to the non-OA alleles (p ¼ 0.0025 and p > 0.0001, respectively).
Conclusions: In OA cartilage, our data does not support an association
of rs10492367 with OA by mediating its effect on PTHLH or KLHDC5
expression. This may be due to the current analysis being limited to the
aforementioned genes in end stage OA cartilage, as the OA associated
regionmay be exerting its effects on other genes, in other tissue types or
at different stages of development. However, luciferase reporter assays
in an osteosarcoma cell line identiﬁed two intergenic SNPs in high LD
with the associated SNP rs10492367 that independently resulted in
reduced enhancer activity when the OA associated alleles were present.
This current research therefore highlights the functional activity of the
OA associated region marked by rs10492367.
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ADIPOSE TISSUE ASSOCIATED GENES IN HAND OSTEOARTHRITIS IN
FINNISH WOMEN
S. H€am€al€ainen, S. Solovieva, T. Vehmas, P. Leino-Arjas, A. Hirvonen.
Finnish Inst. of Occupational Hlth., Helsinki, Finland
Purpose: Osteoarthritis (OA) is the most common joint disorder, the
joints of the hand being the most frequent site affected. Available evi-
dence suggests that genetic factors may play a major role in the etiology
of OA.We chose to analyze in our hand OAmaterial 21 single nucleotide
polymorphisms (SNPs) from 10 adipose tissue associated genes (FTO,
LEP, LEPR, ADIPOQ, RETN, NAMPT, SERPINA12, ITLN, RARRES2 and
APLN) and their association with OA.
Methods: Bilateral hand radiographs of 542 occupationally active Fin-
nish female dentists and teachers aged 45-63 years were examined and
classiﬁed for the presence of OA by using reference images. The geno-
types were determined by PCR-based methods. Data regarding ﬁnger
joint pain and other risk factors were collected by a questionnaire.
Associations between the SNPs and hand OA were studied by IBM SPSS
statistical package Version 20 using principle component analysis based
genetic weighted scores and logistic regression.
Results: Association of studied SNPs to hand OA phenotypes were
found from LEPR, RARRES2, RETN and APLN genes. FTO and INTL SNPs
had borderline signiﬁcant associations to hand OA phenotypes. Princi-
ple component analysis resulted in 11 principle components weighted
by their genetic scores. Component 4 including four ADIPOQ SNPs,
component 6 including RARRES2 SNP, and component 8 including APLN
SNP had association to hand OA phenotypes.
Conclusions: Our results suggest that ADIPOQ, LEPR, RARRES2, RETN
and APLN genes may play role in hand OA etiology in Finnish women.
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THE OSTEOARTHRITIS ASSOCIATION MARKED BY SNP rs6094710
MEDIATES ITS EFFECT BY REDUCING THE EXPRESSION OF NCOA3
IN JOINT TISSUES
M.D. Rushton, F.H. Gee, L.N. Reynard, J. Loughlin. Newcastle Univ.,
Newcastle upon Tyne, United Kingdom
Purpose: Recently it has been reported that the rare single nucleotide
polymorphism (SNP) rs6094710 is associated with hip osteoarthritis
(OA) in European populations. The SNP is a G/A transition, with the A-
allele having a frequency of 4%. The A-allele is more common in OA
cases versus controls and this association reached genome-wide sig-
niﬁcance, with a p-value of 7.9  109 and odds ratio of 1.28. rs6094710
is intergenic, maps to chromosome 20q12 and is located upstream of
the gene NCOA3, which codes for nuclear receptor co-activator 3. This
protein interacts with nuclear hormone receptors and has histone
acetyltransferase activity. Prior to the genetic study there were noreports of this protein having a role in OA. rs6094710 is in perfect
linkage disequilibrium with rs6094752, a missense polymorphism
leading to an amino acid change at position 218 of the NCOA3 protein.
However, scrutiny of a variety of public databases reveals that this
substitution is benign. This, combined with the absence of other pro-
tein-coding changes, make it probable that the 20q12 association
mediates its affect bymodulating gene expression. The aim of this study
therefore was to investigate the effect of genotype at rs6094710 on the
expression of NCOA3.
Methods: DNA and RNA were extracted from the cartilage of OA
patients who had undergone elective joint replacement surgery. DNA
was used to genotype patients at rs6094710. cDNA was synthesized
from the RNA. Using real-time quantitative PCR (qPCR) we initially
assessed whether genotype at rs6094710 correlated with overall
expression of NCOA3. We next assessed allelic expression imbalance
(AEI) of NCOA3, using the transcript SNP rs6094752 as a perfect proxy
for rs6094710. AEI was measured in heterozygotes by pyrosequencing,
with DNA providing the 1:1 ratio to which the cDNA ratios were com-
pared. We have previously generated gene expression microarray data
for hip cartilage from patients who had undergone joint replacement
surgery due to either OA (n¼ 11) or a neck-of-femur (NOF) fracture (n¼
13). This latter cartilage serves as a non-OA control. We used this data to
compare the expression of NCOA3 between OA and non-OA hip
cartilage.
Results: We performed qPCR analysis on the cartilage cDNA of 47 OA
patients and observed that overall NCOA3 expression correlated with
genotype at rs6094710 (p ¼ 0.021; t-test). Reduced expression of
NCOA3 was observed in individuals carrying a copy of the OA associated
A-allele. AEI analysis conﬁrmed the reduced expression from this allele,
which produced an average of 37% less transcript than the G allele (p <
0.001; t-test). This AEI was also observed in fat pad (also an average 37%
reduction) and synovial membrane (51% reduction) from OA patients,
and in both males and females. Analysis of our microarray data revealed
that NCOA3 is up-regulated 1.27 fold (p¼ 0.004; Mann–Whitney U test)
in OA hip cartilage relative to control NOF cartilage.
Conclusions: Our results indicate that the OA association signal marked
by rs6094710 is mediating its effect through a reduced expression of the
gene NCOA3. Based on our microarray data we hypothesize that NCOA3
expression needs to increase to attenuate the OA disease process but
that this increase is hampered in individuals carrying the A-allele of
rs6094710, which therefore acts as an OA risk allele. Much more
detailed functional studies of the gene and its encoded protein are now
merited.
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KNEE OSTEOARTHRITIS GENETICS IN FINNISH HEALTH 2000 SURVEY
M. Welling y, S. H€am€al€ainen z, A. Ojaj€arvi z, A. Hirvonen z,
M. Heli€ovaara x, P. Leino-Arjas z, M. M€annikk€o y, J. Karppinen k,z. y Inst. of
Hlth.Sci., Univ. of Oulu, Oulu, Finland; z Finnish Inst. of Occupational Hlth.,
Helsinki, Finland; xNatl. Inst. of Occupational Hlth., Helsinki, Finland;
kDept. of Physical and Rehabilitation Med., Oulu, Finland
Purpose: The aim of the study was to elucidate the genetic back-
ground of osteoarthritis (OA) and its correspondence to the genetics
of overweight and metabolic syndrome (MetS) in Finnish population.
OA and MetS share age and obesity as risk factors, and they both
have been considered as an inﬂammatory disease in which different
inﬂammatory mediators (for example cytokines, lipid derivatives,
reactive oxygen species) are released by cartilage, bone and syno-
vium. Obese patients with MetS have higher risk of developing OA
than obese patients without MetS. Investigators are now assessing
how MetS as a whole is linked to OA, and some have already
nominated ‘metabolic OA’ as the ﬁfth component of MetS. Genome-
wide association studies (GWAS) have identiﬁed several single
nucleotide polymorphisms (SNPs) associated with obesity and MetS.
One of the most investigated genes has been FTO (fat mass- and
obesity-associated) that regulates appetite. Genome-wide association
studies have identiﬁed that polymorphisms in the FTO gene are
associated also with risk of OA.
Methods: We chose to analyze 58 SNPs from 45 genes and their asso-
ciation to knee OA in Finnish Health 2000 Survey material. The Health
2000 Survey was conducted in Finland between fall 2000 and spring
2001. It is a representative sample of the Finnish population (n ¼ 8028).
The subjects were aged between 30 and 99. Knee osteoarthritis was
diagnosed in 6.1 % of men and 8.3 % of women. For the genetic analyses
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osteoarthritis and 5348 controls. 186 of the patients were categorized to
a group of ‘probable osteoarthritis’ and 216 to a group of ‘deﬁnite
osteoarthritis’ using standard criteria based on medical history, symp-
tom history and physical status. The genotypes were determined by
PCR-based methods, iPlex/Sequenom MALTI-TOF mass array analyzer
and OpenArray. Background data were collected by a questionnaire.
Associations between the SNPs and knee OA were studied by SAS and
IBM SPSS statistical package Version 20.
Results: The nucleotide substitution A>T in FTO gene (rs9939609)
was found to correlate with osteoarthritis. Surprisingly this correla-
tion was statistically signiﬁcant only in the ‘probable osteoarthritis’-
group (OR ¼ 1,566, 95% CI: 1,040-2,360; p ¼ 0,032) and not in the
‘deﬁnite osteoarthritis’ group (OR ¼ 1,063, 95% CI: 0,713-1,584; p ¼
0,765). The result remained signiﬁcant in the ‘probable osteoarthritis’
group when adjusted with age and gender (OR ¼ 1,608, 95% CI:
1,047-2,470; p ¼ 0,030). When adjusted with BMI, the signiﬁcance
became non-signiﬁcant (OR ¼ 1,526, 95% CI: 0,990-2,344; p ¼
0,056).
Conclusions: Our results suggest that FTO gene has a role in knee OA.
However, it seems that the interaction is at least partly explained by
BMI.Change in semi-quantitative feature at 24 months and prediction of case control status OR (95% CI) p
Semi-quantitative feature Case (JSL and pain) (n ¼ 194)
vs. all controls (n ¼ 406)
Super Control
(n ¼ 200)
Pain Case (n ¼ 103) JSL Case (n ¼ 103) Case (JSL and pain) (n ¼ 194)
Change in number of subregions
affected by any BML
1.1 (1.0,1.4) 0.1572 Ref 1.0 (0.8,1.3) 0.8961 1.4 (1.1,1.8) 0.0059 1.3 (1.0,1.6) 0.0375
Max change in BML score across
all subregions in knee
1.2 (1.0,1.4) 0.0122 Ref 0.9 (0.7,1.1) 0.3548 1.5 (1.2,1.9) 0.0013 1.3 (1.1,1.6) 0.0037
Change in number of medial
tibio-femoral subregions
affected by any BML
1.5 (1.1,1.8) 0.0023 Ref 0.9 (0.6,1.4) 0.7385 2.0 (1.4,2.8) 0.0002 1.8 (1.3,2.5) 0.0001
Max change in BML score in
medial tibio-femoral subregion
1.5 (1.3,1.8) <0.0001 Ref 1.0 (0.8,1.4) 0.7878 2.3 (1.8,2.9) <0.0001 2.0 (1.6,2.5) <0.0001
Change inter-condylar synovitis 2.2 (1.4,3.6) 0.0015 Ref 1.0 (0.5,2.2) 0.9106 1.7 (0.8,3.6) 0.1615 2.6 (1.4,4.7) 0.0018
Change in whole knee effusion 2.2 (1.6,2.8) <.0001 Ref 1.2 (0.8,1.8) 0.2946 1.5 (1.0,2.1) 0.0318 2.5 (1.8,3.5) <0.0001Imaging
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PRELIMINARY ASSESSMENT OF PREDICTIVE VALIDITY OF SEMI-
QUANTITATIVE MRI BIOMARKERS IN KNEE OA – THE FNIH OA
BIOMARKERS CONSORTIUM
D.J. Hunter y, M. Nevitt z, J. Collins x, F.W. Roemer k, J. Lynch z, V. Kraus{,
J.N. Katz x, E. Losina x, J.M. Jordan#, A. Guermazi k. yUniv. of Sydney, St
Leonards, Australia; zUCSF, San Francisco, CA, USA; xHarvard Univ.,
Boston, MA, USA; kBoston Univ., Boston, MA, USA; {Duke Univ.,
Durham, NC, USA; #UNC, Chapel Hill, NC, USA
Purpose: Identiﬁcation of biomarkers associated with OA disease pro-
gression is of critical importance to advance the development of disease
modifying therapies. The objective of this study is to investigate if
change in semi-quantitative measures of joint morphology over 24
months is associated with clinically relevant progression in knee OA
over a 48-month follow-up period.
Methods: The FNIH OA Biomarkers Consortium undertook a nested case-
control study of progressive knee OA within the Osteoarthritis Initiative
(OAI). The case group (n ¼ 194) is deﬁned by the combination of knee
radiographic outcome (medial tibiofemoral joint space loss (mTF JSL)
0.7 mm) and symptom outcome (persistent worsening inWOMAC pain
score, reaching a minimum clinically important threshold of 9 points
(change from baseline) on a 0-100 normalised scale), each achieved for
the ﬁrst time at the 24, 36 or 48 month follow-up compared to baseline.
Main inclusion criteria were a Kellgren Lawrence grade (KLG) 1, 2 or 3 at
baseline from central reading and availability of knee radiograph and
magnetic resonance images (MRIs) at baseline and 24 months. Controls
(n ¼ 406) were knees eligible for the study that did not meet both
endpoint criteria, and consisted of: 200 super controls with noworsening
of either factor (pain or mTF JSL), 103 subjects with JSL but no pain
increase and 103with a persistent increase in pain but not JSL. KneeMRIs(not contrast enhanced) at baseline, 12 and 24 months were scored using
the MRI Osteoarthritis Knee Score grading systems for bone marrow
lesions (BMLs), intercondylar synovitis and effusion. BML, synovitis and
effusion score changes were categorized as improved, no change, wors-
ened within grade, worsened by one grade, or worsened by more than
one grade. Analyses were performed for change in the whole knee and,
for BMLs only, also for change in the medial tibio-femoral compartment.
Logistic regressionwas used to assess the risk of case status adjusting for
baseline age, sex, BMI, KLG and baseline pain.
Results: 194 cases of mean age 62 years, mean BMI 30.7 and 57% female
were compared to 406 controls of mean age 61 years, mean BMI 30.7 and
60% female. BML change from BL to 24 months was associated with case
status - particularly the maximum change in BML score in the medial
tibiofemoral compartmentOR 1.5 (95%CI 1.3,1.8) and change innumberof
subregions affected in the medial tibiofemoral compartment OR 1.5 (95%
CI 1.1,1.8) (Table). Change in effusion, OR 2.2 (95% CI 1.6,2.8), and synovitis,
OR 2.2 (95% CI 1.4,3.6), were both strong predictors of case status. There
were differential effects of BML change on the 3 types of case status (pain
case vs. JSL case vs. JSL and pain case, each compared to super controls)
with strong association with JSL cases as opposed to pain cases.
Conclusion: Change in semi-quantitative MRI features (BMLs, synovitis
and effusion) are potent predictors of clinical outcome. Intriguingly, the
prediction of clinical outcome from BMLs, synovitis and effusion
appears to be associated with stronger effects on structure.428
QUANTITATIVE MRI MEASURES OF BONE MARROW LESION VOLUME
PREDICT TOTAL KNEE REPLACEMENT
C. Ratzlaff y, R.L. Russell y, K. Kwoh z, M. Hannon x, J. Grago x,
A. Guermazi k, F. Roemer{, M. Jarraya k, D. Hunter#, J. Duryea y.
yBrigham and Women’s Hosp., Boston, MA, USA; zUniv. of Arizona,
Tucson, AZ, USA; xUniv. of Pittsburgh and Pittsburgh VAHS, Pittsburgh,
PA, USA; kBoston Univ. Sch. of Med., Boston, MA, USA; {Univ. of
Erlangen, Erlangen, Germany; #Univ. of Sydney, New South Wales,
Australia
Purpose: Quantitative MRI (qMRI) measures in knee osteoarthritis (OA)
capable of predicting key clinical endpoints such as total knee
replacement (TKR) have promise as prognostic biomarkers. Recently, it
was reported that very large BML volume (measured semi-quantita-
tively) in the medial tibiofemoral joint predicted a TKR 1 year later. We
now use a recently validated rapid qMRI software tool to examine
whether BML volume and change in volume predicts TKR 1 and 2 years
later. The purpose of this study was to examine the longitudinal rela-
tionship between BML volume and those who received a TKR, com-
pared with control knees with the same radiographic grade that did not
receive a TKR.
Materials and methods: A nested case-control study was conducted in
the Osteoarthritis Initiative (OAI), a multicenter cohort of 4796 partic-
ipants with or at risk for knee OA. Subjects who received TKR by the 48-
month visit who also had MRI scans (3T sagittal intermediate-weighted
turbo spin-echo fat-suppressed, 0.357  0.357  3.0 mm, TR 3200 ms,
TE 30 ms, intermediate-weighted) available for the 12 and 24 month
visit prior to the TKR were designated cases. Cases were matched 1:1
with subjects who did not receive TKR but were the same radiographic
disease grade (K–L grade score), same gender and age of the case.
Quantitative BML volumes in the tibia, femur and patella were
